Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Celltrion (068270) – Decision on Disposal of Treasury Shares / 2026-01-21 Disclosures
  • [Research] SK hynix (000660 / SKHY) – IBK Securities | AI Servers · Server DRAM · Supply Tightness / 2026-04-15 RESEARCH
  • [Disclosure] Hanmi Semiconductor (042700) – Corporate Value-Up Plan / 2025-12-26 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Market Measures on Stock Futures and Options / 2025-04-22 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2025-01-23 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Provisional Consolidated Financial Results / 2025-11-03 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Decision on Cash and In-Kind Dividend / 2024-10-31 Semiconductors
  • [Disclosure] SK Hynix (000660 / SKHY) – Announcement of Investor Relations (IR) Event / 2024-07-04 Semiconductors

[Disclosure] SK Hynix (000660 / SKHY) – Decision on Listing of Shares on Foreign Securities Market (Correction) / 2026-07-10

Posted on July 10, 2026August 11, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART
Market: KOSPI (000660)

💡 3-Second Summary

SK Hynix has finalized the terms for its foreign listing, confirming 177,900,000 American Depositary Receipts (ADRs), backed by 17,790,000 new common shares, to be listed on the U.S. Nasdaq exchange following demand forecast results.

📊 [Key Summary & Financial Figures]

  • Company Name: SK Hynix Inc.
  • Type & Number of Shares to be Listed: Common Shares 17,790,000 shares (Total issued shares: 712,702,365 shares)
  • Offering Method: New Share Issuance 17,790,000 shares (No secondary offering)
  • Securities to be Listed: DR Listing 177,900,000 shares (Underlying share to ADR ratio of 1 : 10 applied)
  • Listing Exchange (Country): U.S. Nasdaq Stock Market (Nasdaq Global Select Market)
  • Purpose of Financing: Facility Capital
    • (1) Yongin Semiconductor Cluster Phase 1 Fab (construction investment)
    • (2) Cheongju P&T7 Advanced Packaging Fab (including construction, equipment, and incidental expenses)
    • (3) Acquisition of machinery – EUV Scanner construction and facility investment
  • Purpose of Foreign Listing: Expansion of global investor base
  • Confirmed Key Schedule:
    • Expected Listing Date: July 10, 2026
    • Subscription & Payment Date: July 14, 2026
  • Board Resolution Date: June 24, 2026 (6 outside directors present, 0 absent)
  • Other Key Correction Details:
    • Revised initial maximum limit estimates to finalized numbers reflecting bookbuilding results
    • Reflected confirmed dates for expected listing (July 10, 2026) and subscription/payment (July 14, 2026)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verifying Confirmed Listing Scale and Schedule Following Demand Forecast Results

This correction disclosure was submitted to state the finalized listing terms—such as the number of ADRs (177,900,000 shares), underlying common shares (17,790,000 shares), listing date (July 10, 2026), and payment date (July 14, 2026)—determined through the bookbuilding process. Reviewing the finalized listing scale and schedule against initial reference figures is important to understand the transaction structure and progress. Relevant progress and details can be confirmed in subsequent periodic reports (Quarterly, Half-Year, or Annual Reports) and related disclosures.

📢 Disclaimer and Source Notice

Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s DART system.

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] SK Hynix (000660 / SKHY) – Decision on Issuance of Depositary Receipts (DR) (Correction) / 2026-07-10
Next Post: [Disclosure] SK Hynix (000660 / SKHY) – Decision on Capital Increase (Correction) / 2026-07-10

Related Posts

  • [Disclosure] Samsung Electronics (005930) – Decision on Disposal of Treasury Stock / 2026-07-13 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-11-11 Disclosures
  • [Disclosure] ISU PETASYS (007660) – Decision on Acquisition of Equity-Related Bonds / 2025-01-23 Semiconductors
  • [Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Announcement / 2024-11-18 Semiconductors
  • [Disclosure] ISU PETASYS(007660) – Corporate Value-up Plan (Voluntary Disclosure) / 2025-04-30 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Additional Listing (Exercise of Stock Options) / 2025-05-23 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Investor Relations (IR) Holding Announcement / 2025-04-08 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Investor Relations (IR) Holding Announcement / 2025-10-14 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Shares and Investment Certificates of Other Corporations (Correction) / 2026-08-10 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Decision on Acquisition of Shares and Equity Securities of Other Corporations / 2025-03-05 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Decision on Cash and In-Kind Dividend / 2024-10-31 Semiconductors
  • [Disclosure] Celltrion (068270) – Execution of Exclusivity Agreement for Acquisition of US API Facility Entity (Preferred Bidder Selection) (Correction) / 2025-09-23 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Execution of Material Sales/Supply Contract / 2024-07-02 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme